Lighting the Path to Cures

Transforming Medicine with AI

We are harnessing AI to accelerate breakthrough biologic therapies in difficult immune-mediated diseases and improve the lives of patients with significant unmet medical need.

Where AI meets disease biology and drug development

Step into our world, where innovation and AI meet disease biology and drug development. Built on intelligent design and guided by people who care about transforming healthcare, our technology is redefining what is possible in biologics development, from how we select targets to how we engineer the molecules.

A new generation of AI-enabled therapeutics

Our drug candidates leverage validated mechanisms of action and differentiated designs to deliver more effective, convenient treatment options for patients facing difficult-to-treat diseases. See where each program stands, from discovery through the clinic, and the patients each one is built for.

The latest from Ailux

Ailux Presents Preclinical Data on AI-optimized, CD3-Masked CD19×BCMA T-Cell Engager at EULAR 2026
Ailux Appoints Maria Belvisi, Ph.D., as Chief Scientific Officer
Ailux Selected for Digital Oral and Poster Presentations at ECCO’26, Highlighting Potential for Novel IBD Treatment